Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Conditions
Interventions
Intervention1: use of oral finasteride and oral minoxidil in androgenic alopecia: dose finasteride - 1mg
dose of minoxidil-2.5mg
frequency- Once daily
Route - oral
Duration of treatment- 6 months
C
Sponsors
Krishna institute of medical sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male patient comes with history or clinical findings suggestive of androgenic alopecia. 2. Age group more than 18 years of age and less than 50 years of age 3. Hamilton grade 2-6 4. Have given written consent before investigation and starting the drug. 5. Be able and willing and fit , in the view of investigator , to comply all study procedures
Exclusion criteria
Exclusion criteria: 1. Patient who is hypotensive or hypertensive 2. Patients with grade 1 or grade 7 alopecia. 3. Patient with cardiac diseases (including angina, coronary artery disease, recent or acute myocardial infarction, pericardial effusion) 4. Patients with cerebrovascular diseases 5. Patients with deranged liver and kidney function. 6. Patients allergic to finasteride or minoxidil. 7. Patient on any treatment for androgenic alopecia for last 2 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.average hair thickness improvement by more than 10 percent 2.Increase in terminal vellus hair ratio.Timepoint: Baseline 4 weeks 8 weeks 12 weeks 16 weeks 20 weeks 24 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| clinical photographyTimepoint: Baseline 4 weeks 8 weeks 12 weeks 16 weeks 20 weeks 24 weeks | — |
Countries
India
Contacts
Public ContactMohak Arora
Krishna institute of medical sciences
Outcome results
None listed